DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rallied 2.11% to $179.89 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.43% to 6,939.03 and Dow Jones Industrial Average falling 0.36% to 48,892.47.
This was the stock's fifth consecutive day of gains.
Biogen Inc. closed 5.42% below its 52-week high of $190.20, which the company achieved on January 9th.
The stock outperformed some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 0.02% to $227.25, Pfizer Inc. $(PFE)$ rose 1.30% to $26.44, and AbbVie Inc. $(ABBV)$ rose 1.17% to $223.01.
Trading volume (1.5 M) remained 482,187 below its 50-day average volume of 2.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled January 30, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
January 30, 2026 17:01 ET (22:01 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments